CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹240 Cr | ₹1,547 Cr | ₹128 Cr | ₹128 Cr |
What is the latest Operating Profit of CORONA REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹240 Cr |
| Mar2025 | ₹1,547 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹128 Cr |
How is Operating Profit of CORONA REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹240 Cr | -84.49 | |
| Mar2025 | ₹1,547 Cr | 1,109.05 | |
| Mar2024 | ₹128 Cr | 0.00 | |
| Mar2023 | ₹128 Cr | - | |
Compare Operating Profit of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹11,714.0 Cr | 5.7% | 8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 5.7% |
8% |
|
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses